[Long-term treatment using prostaglandin E2 in congenital heart defects with the pulmonary circulation being supplied by a patent ductus arteriosus]
- PMID: 3860302
[Long-term treatment using prostaglandin E2 in congenital heart defects with the pulmonary circulation being supplied by a patent ductus arteriosus]
Similar articles
-
Prostaglandin treatment of newborns with ductal-dependent congenital heart disease.Pediatr Ann. 1981 Apr;10(4):29-38. Pediatr Ann. 1981. PMID: 7232040 No abstract available.
-
Use of prostaglandins in cardiopulmonary diseases of the newborn.Semin Perinatol. 1980 Apr;4(2):135-41. Semin Perinatol. 1980. PMID: 6990504 Review. No abstract available.
-
[Prostaglandin treatment of ductus-dependent congenital heart defects].Lakartidningen. 1984 Oct 3;81(40):3619-22. Lakartidningen. 1984. PMID: 6541738 Swedish. No abstract available.
-
[Skeletal side effects of treatment with prostaglandin E1].Rofo. 1984 Oct;141(4):427-30. doi: 10.1055/s-2008-1053163. Rofo. 1984. PMID: 6436918 German.
-
The ductus arteriosus: why and how to manipulate its patency.J Fla Med Assoc. 1983 Sep;70(9):788-93. J Fla Med Assoc. 1983. PMID: 6355376 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical